ATE489959T1 - Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel - Google Patents

Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel

Info

Publication number
ATE489959T1
ATE489959T1 AT02742853T AT02742853T ATE489959T1 AT E489959 T1 ATE489959 T1 AT E489959T1 AT 02742853 T AT02742853 T AT 02742853T AT 02742853 T AT02742853 T AT 02742853T AT E489959 T1 ATE489959 T1 AT E489959T1
Authority
AT
Austria
Prior art keywords
strain
micro
organism
lactobacillus fermentum
oxidative
Prior art date
Application number
AT02742853T
Other languages
English (en)
Inventor
Marika Mikelsaar
Mihkel Zilmer
Tiiu Kullisaar
Heidi Annuk
Epp Songisepp
Original Assignee
Univ Tartu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tartu filed Critical Univ Tartu
Application granted granted Critical
Publication of ATE489959T1 publication Critical patent/ATE489959T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AT02742853T 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel ATE489959T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EEP200100356A EE04580B1 (et) 2001-06-29 2001-06-29 Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
PCT/EE2002/000006 WO2003002131A1 (en) 2001-06-29 2002-06-21 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic

Publications (1)

Publication Number Publication Date
ATE489959T1 true ATE489959T1 (de) 2010-12-15

Family

ID=8161768

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02742853T ATE489959T1 (de) 2001-06-29 2002-06-21 Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel

Country Status (9)

Country Link
US (1) US7244424B2 (de)
EP (1) EP1401457B1 (de)
AT (1) ATE489959T1 (de)
DE (1) DE60238482D1 (de)
DK (1) DK1401457T3 (de)
EE (1) EE04580B1 (de)
ES (1) ES2356119T3 (de)
RU (1) RU2284354C2 (de)
WO (1) WO2003002131A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040170617A1 (en) * 2000-06-05 2004-09-02 Finegold Sydney M. Method of treating diseases associated with abnormal gastrointestinal flora
MXPA05010696A (es) * 2003-04-02 2006-04-18 Axcan Pharma S A Cepa de lactobacillus fermentum y usos de la misma.
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TWI346554B (en) 2008-04-30 2011-08-11 Genmont Biotech Inc Lactobacillus isolates having anti-inflammatory activities and uses of the same
MX2011013188A (es) * 2009-06-30 2012-01-31 Chr Hansen As Metodo para producir un producto lacteo fermentado.
US8735089B2 (en) 2010-01-08 2014-05-27 Compagnie Gervais Danone Method for selecting bacteria with anti-oxidant action
ES2587136T3 (es) 2010-01-08 2016-10-20 Compagnie Gervais Danone Lactobacilos con acción antioxidante
US9707207B2 (en) 2010-05-26 2017-07-18 The United States Of America As Represented By The Department Of Veterans Affairs Method for diagnosing, preventing, and treating neurological diseases
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
BR112013031325A2 (pt) * 2011-06-08 2017-06-06 Organobalance Gmbh cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori
BR112014009946A2 (pt) * 2011-10-27 2017-04-25 Salix Pharmaceuticals Inc "composição, composição farmacêutica ou formulação purgativas e uso das mesmas"
WO2013062034A1 (ja) * 2011-10-28 2013-05-02 株式会社明治 ナチュラルチーズおよびその製造方法
GB201223370D0 (en) * 2012-12-24 2013-02-06 Univ Tartu Method of treatment using lactobacillus fermentum ME-3
US20160279180A1 (en) * 2013-08-23 2016-09-29 Consejo Superior de Investigaciones Científicas ( CSIC) Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof
RS57471B1 (sr) * 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
CN106967630B (zh) * 2016-12-01 2019-12-10 广东省微生物研究所（广东省微生物分析检测中心） 一种发酵乳杆菌及其应用
RU2705250C2 (ru) * 2018-02-05 2019-11-06 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Штамм Lactobacillus fermentum U-21, продуцирующий комплекс биологически активных веществ, осуществляющих нейтрализацию супероксид-аниона, индуцируемого химическими агентами
WO2020214685A1 (en) * 2019-04-16 2020-10-22 Locus Ip Company, Llc Microbe-based emulsifying food additives
RU2757118C2 (ru) * 2019-12-11 2021-10-11 Общество с ограниченной ответственностью "Фармабиотики" Применение клеток штамма Lactobacillus fermentum U-21 для предотвращения патологических изменений в тканях, вызванных оксидативным стрессом
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
CN116574630B (zh) * 2023-01-31 2024-02-20 江苏省农业科学院 具有抑菌和抗氧化活性的乳杆菌、适用于秸秆青贮的复合微生物菌剂及其应用
CN116590175A (zh) * 2023-04-12 2023-08-15 吉林省中科特殊食品创新研究院有限公司 一种发酵乳杆菌elf041及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
KR100211529B1 (ko) 1997-04-28 1999-08-02 박원훈 유해 미생물 억제 활성을 갖는 신규 내산성 락토바실러스 속 미생물 및 이를 함유하는 가축용 생균활성제
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
RU2133272C1 (ru) 1998-06-11 1999-07-20 Акционерное общество открытого типа "Биомед" им.И.И.Мечникова Штамм бактерии lactobacillus fermentum 90-ts-4(21), используемый для получения эубиотического препарата для применения в гинекологической практике
ID30071A (id) * 1998-12-11 2001-11-01 Urex Biotech Inc Pemberian oral lactobacillus untuk pengobatan dan pencegahan infeksi urogental

Also Published As

Publication number Publication date
ES2356119T3 (es) 2011-04-05
EE04580B1 (et) 2006-02-15
WO2003002131B1 (en) 2003-03-06
US7244424B2 (en) 2007-07-17
RU2003137810A (ru) 2005-05-20
RU2284354C2 (ru) 2006-09-27
EP1401457A1 (de) 2004-03-31
US20040151708A1 (en) 2004-08-05
EE200100356A (et) 2003-02-17
DE60238482D1 (de) 2011-01-13
EP1401457B1 (de) 2010-12-01
WO2003002131A1 (en) 2003-01-09
DK1401457T3 (da) 2011-01-17

Similar Documents

Publication Publication Date Title
ATE489959T1 (de) Mikroorganismus stamm lactobacillus fermentum me- 3 als neues antioxidatives probiotisches mittel
Aguilar-Galvez et al. Potential of tara (Caesalpinia spinosa) gallotannins and hydrolysates as natural antibacterial compounds
Piekarska-Radzik et al. Mutual influence of polyphenols and Lactobacillus spp. bacteria in food: A review
Zaineldin et al. Bacillus subtilis as probiotic candidate for red sea bream: growth performance, oxidative status, and immune response traits
Divyashri et al. Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence
Kumar et al. Anticarcinogenic effect of probiotic fermented milk and chlorophyllin on aflatoxin-B1-induced liver carcinogenesis in rats
Sharma et al. Dietary supplementation of milk fermented with probiotic Lactobacillus fermentum enhances systemic immune response and antioxidant capacity in aging mice
Gotteland et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
Steinbrenner et al. Dietary selenium in adjuvant therapy of viral and bacterial infections
Abuelsaad et al. Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model
Tang et al. Health promoting activities of probiotics
Sunanliganon et al. Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation
Zhang et al. Antioxidant capacity and prebiotic effects of Gracilaria neoagaro oligosaccharides prepared by agarase hydrolysis
Pellizzoni et al. Antimicrobial activity of different Aloe barbadensis Mill. and Aloe arborescens Mill. leaf fractions
Zhou et al. Lactobacillus plantarum ZJ316 attenuates Helicobacter pylori-induced gastritis in C57BL/6 mice
Kumar et al. The ameliorative effects of probiotic Lactobacillus fermentum strain RS-2 on alloxan induced diabetic rats
Brown et al. Activities of muscadine grape skin and quercetin against Helicobacter pylori infection in mice
ITRM20110475A1 (it) Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
Kataoka et al. Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats
Moorthy et al. Protective role of lactobacilli in Shigella dysenteriae 1–induced diarrhea in rats
Zhao et al. Probiotic role and application of thermophilic Bacillus as novel food materials
Lim Purification and characterization of two bacteriocins from Lactobacillus brevis BK11 and Enterococcus faecalis BK61 showing anti-Helicobacter pylori activity
Mandal et al. Effect of newly isolated Lactobacillus ingluviei ADK10, from chicken intestinal tract on acetaminophen induced oxidative stress in Wistar rats
Lee et al. Antioxidant and antibacterial activities of Lactobacillus-fermented Artemisia annua L. as a potential fish feed additive
Namba et al. Inhibitory Effects ofBifidobacterium longumon EnterohemorrhagicEscherichia coliO157: H7

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401457

Country of ref document: EP